tiprankstipranks
Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP)
LSE:BXP
UK Market
BXP
Beximco Pharmaceuticals Limited Sponsored GDR RegS
RESEARCH TOOLSreports

Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP) Income Statement

Compare
5 Followers

Beximco Pharmaceuticals Limited Sponsored GDR RegS Income Statement

Last quarter (Q2 2023), Beximco Pharmaceuticals Limited Sponsored GDR RegS's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Beximco Pharmaceuticals Limited Sponsored GDR RegS's net income was $1.24B. See Beximco Pharmaceuticals Limited Sponsored GDR RegS’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 17.31B$ 41.14B$ 13.92B$ 11.90B$ 10.62B
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 176.71M$ 569.81M$ 203.96M$ 193.82M$ 166.04M
EBITDA
$ 9.37B$ 27.12B$ 7.18B$ 5.64B$ 4.93B
Operating Income
$ 7.17B$ 19.78B$ 6.66B$ 5.51B$ 4.87B
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ 4.61B$ 21.34B$ 5.13B$ 3.51B$ 3.03B
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Beximco Pharmaceuticals Limited Sponsored GDR RegS Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis